Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE3
A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- NA
Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
The Oronasal Microbiota in Pediatric Oncology Patients
- Status
- COMPLETED
- Phase
- N/A
CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AML
- Status
- COMPLETED
- Phase
- PHASE2
Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+
- Status
- COMPLETED
- Phase
- NA
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
- Status
- UNKNOWN
- Phase
- PHASE4
Beat AML Core Study
- Status
- COMPLETED
- Phase
- N/A
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trial of BP1001 (Liposomal Grb2 Antisense Oligonucleotide) in Combination With Dasatinib in Patients With Ph + CML Who Have Failed TKI, Ph+ AML, Ph+ MDS
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Low-Dose Daunorubicin in Relapsed/Refractory Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Invasives Aspergillosis in Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A
Transfusion in Adult Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A